Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Rozzano
Clinical trial register · Italy

Clinical Trials in Rozzano, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Rozzano 40 Milan 11 Bergamo 3 Genova 2 Brescia 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Istituto Clinico Humanitas40 AstraZeneca40 Merck Sharp & Dohme LLC27 Novartis Pharmaceuticals26 AbbVie21 Clear sponsor filter
Site location
Rozzano40 Milan11 Bergamo3 Genova2 Brescia2
All 24 locations
Target enrolment
to

Trials with a site in Rozzano

40 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Nutritional Supplementation to Improve Colorectal Cancer Surgery
NCT07599501Colorectal Cancer, Colorectal Surgery
Istituto Clinico Humanitas
Not applicable
190
Rozzano
2026-09-30
Recruiting
Istituto Clinico Humanitas
Observational
20
Rozzano
2026-06-22
Recruiting
Istituto Clinico Humanitas
Observational
50
Rozzano
2026-05-29
Active, closed
Hereditary Influences on Pulmonary Fibrosis Trajectories
NCT07580053Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder), Idiopathic Pulmonary Fibrosis (IPF), Telomere Disease, Progressive Pulmonary Fibrosis
Istituto Clinico Humanitas
Observational
250
Rozzano
2026-04-01
Active, closed
Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases.
NCT07577115Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder), Exposure Occupational, Occupational Exposure
Istituto Clinico Humanitas
Observational
1,000
Rozzano
2026-04-01
Recruiting
The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)
NCT07491419Bloodstream Infection, Gram-Negative Infections, Gram-Positive Infections, Bacteremia Sepsis
Istituto Clinico Humanitas
Not applicable
400
Rozzano
2026-03-19
Recruiting
Istituto Clinico Humanitas
Not applicable
44
Rozzano
2026-02-16
Not yet open
Istituto Clinico Humanitas
Observational
190
Rozzano
2026-01-31
Recruiting
RIght VEntricle Response to Major Lung Resection in VATS and Robotic Surgery
NCT07362342Lung Surgery, Right Ventricular Function
Istituto Clinico Humanitas
Observational
100
Rozzano
2026-01-20
Not yet open
Istituto Clinico Humanitas
Not applicable
166
Rozzano
2026-01-19
Recruiting
HUmanitas PROtontherapy (HU-PRO)
NCT07317245Cancer, Proton Therapy
Istituto Clinico Humanitas
Observational
500
Rozzano
2026-01-12
Recruiting
Istituto Clinico Humanitas
Observational
53
Milan, Rozzano
2026-01
Recruiting
Critical Illness Weakness Outside the Intensive Care Unit.
NCT07478367Critical Illness Polyneuromyopathy, Critical Illness Polyneuropathy, Critical Illness Myopathy
Istituto Clinico Humanitas
Observational
300
Rozzano
2025-11-18
By invitation
Istituto Clinico Humanitas
Observational
266
Rozzano
2025-07-21
Recruiting
Istituto Clinico Humanitas
Observational
500
Rozzano
2025-04-04
Recruiting
Istituto Clinico Humanitas
Observational
49
Bergamo, Milan, Rozzano
2025-04-04
Recruiting
Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis
NCT07790614IPF, ILD, Interstitial Lung Disease (ILD), Interstitial Lung Diseases
Istituto Clinico Humanitas
Observational
156
Rozzano
2025-03-25
Not yet open
Istituto Clinico Humanitas
Not applicable
50
Rozzano
2025-03-01
Not yet open
Istituto Clinico Humanitas
Not applicable
60
Rozzano
2025-03-01
Recruiting
External Validation of the BREF Models
NCT06669312Acute Respiratory Failure, Oxygen Inhalation Therapy, Respiratory Distress
Istituto Clinico Humanitas
Observational
250
Rozzano
2025-01-01
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
NCT07401615Non Small Cell Lung Cancer, Pulmonary Stereotactic Radiotherapy
Istituto Clinico Humanitas
Observational
150
Bergamo, Bologna, Catania, Milan, Rozzano, Naples, Roma, Venezia
2024-11-25
Not yet open
Istituto Clinico Humanitas
Observational
174
Rozzano
2024-07-31
Recruiting
Istituto Clinico Humanitas
Observational
472
Rozzano
2024-03-26
Recruiting
Istituto Clinico Humanitas
Observational
340
Rozzano
2023-11-30
Recruiting
Istituto Clinico Humanitas
Not applicable
75
Rozzano
2023-11-01
Recruiting
Istituto Clinico Humanitas
Not applicable
1,800
Rozzano
2023-09-21
Recruiting
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
NCT06918912Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma (HGBCL), B-Cell Lymphoma Treatment, Relapsed or Refractory Lymphoma
DrugLoncastuximab Tesirine
Istituto Clinico Humanitas
Phase 2
50
Alessandria, Bologna, Cuneo, Milan, Rozzano, Roma
2023-06-16
Recruiting
Istituto Clinico Humanitas
Observational
200
Rozzano
2023-06-09
Active, closed
Istituto Clinico Humanitas
Not applicable
44
Rozzano
2023-03-06
Recruiting
Istituto Clinico Humanitas
Not applicable
146
Brescia, Florence, Rozzano, Milan, Naples, Rome, Terni
2023-01-31
Active, closed
Istituto Clinico Humanitas
Not applicable
150
Rozzano
2023-01-09
Recruiting
Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule
NCT05693116Nasal Vestibule Carcinoma, Rhinectomy, Nasal Vestibule, Squamous Cell Carcinoma
Istituto Clinico Humanitas
Observational
300
Rozzano, Cagliari, Milan, Varese
2022-12-01
Recruiting
Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation
NCT06892223Acute Myeloid Leukaemia, MDS (Myelodysplastic Syndrome), MPN (Myeloproliferative Neoplasms)
DrugMonalizumab
Istituto Clinico Humanitas
Phase 2
42
Genova, Rozzano
2021-12-03
Active, closed
Istituto Clinico Humanitas
Not applicable
50
Rozzano
2021-10-05
Active, closed
Istituto Clinico Humanitas
Not applicable
240
Rozzano
2021-09-27
Active, closed
Istituto Clinico Humanitas
Not applicable
50
Rozzano
2021-07-06
Recruiting
Istituto Clinico Humanitas
Not applicable
200
Rozzano
2020-11-17
Active, closed
Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT
NCT04624828Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Istituto Clinico Humanitas
Not applicable
40
Rozzano
2020-10-19
Recruiting
Istituto Clinico Humanitas
Not applicable
850
Rozzano
2019-06-21
Recruiting
Endoscopic Treatment for Zenker's Diverticulum
NCT03948438Zenker Diverticulum
Istituto Clinico Humanitas
Observational
400
Rozzano
2009-01-01
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/rozzano

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Rozzano that also match the filters currently applied.

How many clinical trials are recruiting in Rozzano?

25 of the 40 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 6 have not yet opened recruitment, 8 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rozzano), 40 studies
PhaseStudiesRecruitingShare
Observational211652.5%
Not applicable17742.5%
Phase 2225%

Most active sponsors

Lead sponsors with the most studies (Rozzano)
Lead sponsorStudiesRecruiting
Istituto Clinico Humanitas4025
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.